Skip to main content

Table 4 Forest plot of the endpoints by landmark analyses (365-730 days)

From: Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial